Skip to main content
Quest Diagnostics

Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus

Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus

Authors: Young S, Vaughan L, Yanson K, Eckert K, Li A, Harris J, Ermel A, Williams JA, Al-Ghoul M, Cammarata CL, Taylor SN, Luff R, Cooper C, Van Der Pol B.

Citation: J Clin Microbiol. 2020 Oct 21;JCM.02048-20. doi: 10.1128/JCM.02048-20. Online ahead of print.

Specialties: Infectious Disease, Women's Health/OB/GYN

Related content

Conference Presentation
Moving in the fast lane test design and validation to produce up to date hereditary breast and gynecologic cancer tests
Publication
Contributions of Liquid Based Papanicolaou Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
Publication
BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.